Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

CSL acquires majority stake in Chinese plasma manufacturer Ruide for $352mm, plus earn-out

11 Jul 2017

Executive Summary

CSL Ltd. acquired an 80% stake in Humanwell Healthcare's Wuhan Zhong Yuan Rui De Biological Products Co. (Ruide), a manufacturer of plasma-based therapies, for $352mm in cash, which CSL will fund through an existing debt facility.
Deal Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Synthesis Technologies, Production Processes
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By